New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer. Latest News Breast Cancer Leads Latinas' Cancer Deaths Axois News | June 2021 A Break from Chemo: PARP Inhibitor Shrinks Tumors in Pancreatic Cancer Patients with Mutations Penn Medicine News News | May 2021 DNA Testing Sets Up a Stark Medical Decision Washington Post News | April 2021 Racial Disparities Still Persist in Genetic Testing for BRCA-related Breast Cancer Philly Voice News | April 2021 Next-Generation Sequencing Informs Genetic Testing in Breast Cancer Targeted Oncology News | March 2021 Race Has No Place in Precision Oncology Med Page Today News | March 2021 Hot Topics in Pancreatic Cancer with Kim Reiss Binder Healio News | March 2021 Ambiguous Genetic Test Results Can Be Unsettling. Worse, They Can Lead to Needless Surgeries Washington Post News | February 2021 Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk, Population Study Reveals Penn Medicine News News | January 2021 ALC1 Links Chromatin Accessibility to PARP Inhibitor Response in Homologous Recombination-Deficient Cells Nature Cell Biology News | January 2021 10 Cancer Super Survivors You Need to Follow on Instagram Right Now Parade News | December 2020 Everviolet Chats: Erika Stallings Everviolet News | December 2020 Real-World Integration of Genomic Data into the Electronic Health Record: the PennChart Genomics Initiative Nature News | December 2020 Penn’s Basser Center for BRCA Awards 2020 Basser Global Prize to Bella Kaufman from Israel’s Sheba Medical Center Penn Medicine News News | December 2020 Diagnostic Radiation Below the Waist May Increase Risk for Testicular Cancer Healio News | November 2020 Spotting These Pancreatic Cancer Symptoms Could Save Your Life Yahoo Lifestyle News | November 2020 Global Connections: COVID & CANCER Global Connections News | October 2020 Penn Medicine Researchers Receive $5.4 million Grant to Find Genetic Drivers of Testicular Cancer Penn Medicine News News | October 2020 Pagination First page« First Previous page‹‹ … Page7 Page8 Page9 Page10 Current page11 Page12 Page13 Page14 Page15 … Next page›› Last pageLast »
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News The latest research at Penn Medicine, led by Drs. Minh Than, Ben Stanger and Robert Vonderheide focuses on targeting the earliest, pre-cancerous changes in the pancreas before the cells developed into pancreatic cancer.
A Break from Chemo: PARP Inhibitor Shrinks Tumors in Pancreatic Cancer Patients with Mutations Penn Medicine News News | May 2021
Racial Disparities Still Persist in Genetic Testing for BRCA-related Breast Cancer Philly Voice News | April 2021
Next-Generation Sequencing Informs Genetic Testing in Breast Cancer Targeted Oncology News | March 2021
Ambiguous Genetic Test Results Can Be Unsettling. Worse, They Can Lead to Needless Surgeries Washington Post News | February 2021
Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk, Population Study Reveals Penn Medicine News News | January 2021
ALC1 Links Chromatin Accessibility to PARP Inhibitor Response in Homologous Recombination-Deficient Cells Nature Cell Biology News | January 2021
Real-World Integration of Genomic Data into the Electronic Health Record: the PennChart Genomics Initiative Nature News | December 2020
Penn’s Basser Center for BRCA Awards 2020 Basser Global Prize to Bella Kaufman from Israel’s Sheba Medical Center Penn Medicine News News | December 2020
Diagnostic Radiation Below the Waist May Increase Risk for Testicular Cancer Healio News | November 2020
Penn Medicine Researchers Receive $5.4 million Grant to Find Genetic Drivers of Testicular Cancer Penn Medicine News News | October 2020
